Counterpoint: Test the value of hyperthermia in patients with carcinoma of the cervix being treated with concurrent chemotherapy and radiation

International Journal of Hyperthermia

Volumn 18, Issue 1, 2002, Pages 13-18

  Prosnitz, L ^a   Jones, E ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; HYDROXYUREA;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; DEATH; DRUG EFFICACY; FEMALE; HUMAN; HYPERTHERMIC THERAPY; MULTICENTER STUDY; PELVIS TUMOR; PHASE 3 CLINICAL TRIAL; RECURRENCE RISK; REVIEW; TOXICITY; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; RADIOTHERAPY; UTERINE CERVICAL NEOPLASMS;

EID: 0036150198     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.1080/02656730110083747     Document Type: Review

References (7)

1. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer
2. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage Ib cervical carcinoma
3. Concurrent cisplatin based radiotherapy and chemotherapy for locally advanced cervical cancer
4. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIb-IVa carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group annd Southwest Oncology Group study
5. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high risk early stage cancer of the cervix
6. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumors: A prospective randomized multi centre trial